Indo-Bangla Pharmaceuticals Limited (DSE:IBP)
Bangladesh
· Delayed Price · Currency is BDT 11.80
-0.30 (-2.48%)
At close: Dec 4, 2025
DSE:IBP Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 3, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jul '22 Jul 1, 2022 | Jul '21 Jul 1, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Market Capitalization | 1,371 | 1,546 | 1,975 | 2,036 | 2,186 | 2,230 | Upgrade
|
| Market Cap Growth | 40.48% | -21.77% | -2.97% | -6.88% | -1.96% | -7.22% | Upgrade
|
| Enterprise Value | 1,386 | 1,570 | 2,047 | 2,079 | 2,262 | 2,167 | Upgrade
|
| Last Close Price | 11.80 | 13.29 | 16.98 | 17.78 | 18.70 | 18.63 | Upgrade
|
| PE Ratio | - | - | 234.98 | 80.87 | 16.23 | 14.27 | Upgrade
|
| PS Ratio | 15.05 | 8.75 | 5.28 | 4.20 | 2.80 | 2.58 | Upgrade
|
| PB Ratio | 0.88 | 0.98 | 1.22 | 1.25 | 1.35 | 1.47 | Upgrade
|
| P/TBV Ratio | 0.88 | 0.98 | 1.22 | 1.25 | 1.35 | 1.47 | Upgrade
|
| P/FCF Ratio | - | 65.38 | 46.03 | 42.77 | - | - | Upgrade
|
| P/OCF Ratio | 99.67 | 45.77 | 27.08 | 23.33 | 14.48 | 12.71 | Upgrade
|
| EV/Sales Ratio | 15.21 | 8.89 | 5.47 | 4.29 | 2.89 | 2.50 | Upgrade
|
| EV/EBITDA Ratio | - | 328.22 | 30.53 | 27.74 | 10.81 | 9.00 | Upgrade
|
| EV/EBIT Ratio | - | - | 71.35 | 58.07 | 13.05 | 10.23 | Upgrade
|
| EV/FCF Ratio | - | 66.42 | 47.69 | 43.67 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.02 | 0.03 | 0.05 | 0.05 | - | Upgrade
|
| Debt / EBITDA Ratio | - | 5.06 | 0.65 | 1.01 | 0.41 | - | Upgrade
|
| Debt / FCF Ratio | 1.45 | 1.02 | 1.02 | 1.58 | - | - | Upgrade
|
| Asset Turnover | 0.05 | 0.10 | 0.20 | 0.26 | 0.43 | 0.52 | Upgrade
|
| Inventory Turnover | 0.50 | 0.92 | 1.55 | 1.76 | 2.39 | 2.65 | Upgrade
|
| Quick Ratio | 2.24 | 2.12 | 1.88 | 1.61 | 1.65 | 1.89 | Upgrade
|
| Current Ratio | 5.27 | 4.95 | 4.26 | 3.50 | 3.57 | 4.82 | Upgrade
|
| Return on Equity (ROE) | -2.90% | -2.56% | 0.52% | 1.55% | 8.57% | 10.80% | Upgrade
|
| Return on Assets (ROA) | -1.02% | -0.80% | 0.95% | 1.18% | 5.95% | 7.96% | Upgrade
|
| Return on Capital (ROIC) | -1.16% | -0.91% | 1.06% | 1.31% | 6.71% | 9.16% | Upgrade
|
| Return on Capital Employed (ROCE) | -1.70% | -1.40% | 1.60% | 2.10% | 10.00% | 13.10% | Upgrade
|
| Earnings Yield | -3.36% | -2.65% | 0.43% | 1.24% | 6.16% | 7.01% | Upgrade
|
| FCF Yield | - | 1.53% | 2.17% | 2.34% | -2.26% | -5.99% | Upgrade
|
| Dividend Yield | 0.08% | 0.07% | - | 0.56% | 2.14% | - | Upgrade
|
| Payout Ratio | - | - | 123.72% | 98.46% | 19.97% | 8.49% | Upgrade
|
| Buyback Yield / Dilution | -28.19% | - | - | -2.17% | - | -13.37% | Upgrade
|
| Total Shareholder Return | -28.11% | 0.07% | - | -1.61% | 2.14% | -13.37% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.